Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction

Please use this identifier to cite or link to this item: http://ir.sinica.edu.tw/handle/201000000A/22513

Title:	Efficacy of gene therapy for a prototypical lysosomal storage disease (GSD-II) is critically dependent on vector dose, transgene promoter, and the tissues targeted for vector transduction
Authors:	Ding, E. Hu, H. Hodges, B. L. Migone, F. Serra, D. Xu, F. Chen, Y. T. Amalfitano, A.
Issue Date:	2002
Relation:	Mol Ther 5, 436-446
URI:	http://ir.sinica.edu.tw/handle/201000000A/22513
ISSN:	http://gateway.isiknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=Drexel&SrcApp=hagerty_opac&KeyRecord=1525-0016&DestApp=JCR&RQ=IF_CAT_BOXPLOT
URL:	http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11945071
Appears in Collections:	生物醫學科學研究所

Show full item record

Last Week
0

Last month
1

checked on Jan 3, 2023

Check